These results suggest that Control-PGAM1 could not cross the blood-brain barrier or cell membrane in the spinal cord and that Tat-PGAM1 reduces lipid peroxidation and oxidized arachidonic acid products induced by ROS after spinal cord ischemia. Here, TAT is linked to spinal cord ischemia.